The U.S. supplement market was valued at $48.4 billion in 2021, with an expected compounded annual growth rate of 8.9%.1 In the U.S., where 80% of Americans use dietary supplements, the industry is viewed as trustworthy by the majority of adults (79%).2 However, access to high-quality supplements is continually being threatened by legislation, along with corporate mergers and acquisitions.
Proposed legislation is calling for a federal database for dietary supplements, which could pave the way for the U.S. Food and Drug Administration (FDA) to gain premarket approval power — changing access to supplements as we know it.
Mandatory Product Listing for Supplements May Be Coming
In April 2022, Sens. Dick Durbin, D-Ill., and Mike Braun, R-Ind., introduced the Dietary Supplement Listing Act of 2022.3 The Act would require supplement makers to provide information about their products to the FDA, including (but not limited to):4
- Multinational companies like Bayer, Nestle, Unilever, Proctor & Gamble and Clorox have also been buying up supplement companies at a frenzied pace. In 2018, there were 83 such transactions; this rose to 137 in 2021
- 1, 8, 12, 17, 18, 19, 20, 21 Alliance for Natural Health USA November 15, 2022
- 2 Nutraingredients-usa.com October 22, 2021
- 3, 5 Natural Products Insider November 22, 2022
- 4 Dick Durban April 26, 2022
- 6, 7, 9, 10 Nutritional Outlook May 31, 2022
- 11 FDA, New Dietary Ingredients in Dietary Supplements, Background for Industry
- 13 Dicentra November 14, 2022
- 14 Natural Products Insider November 10, 2022
- 15, 16 Twitter, Chris Masterjohn November 14, 2022
No comments:
Post a Comment